Stem Cell Therapy for Diabetes | James Shapiro | Talks at Google

TL;DR

Dr. Shapiro discusses progress in diabetes treatment through islet and stem cell transplantation, aiming for improved control and potential cures.

Transcript

FRANK: Good afternoon. Thank you for joining us. I'm really excited to introduce Dr. James Shapiro. Dr. Shapiro's been working on diabetes research for a long time, and in particular he's credited with developing the Edmonton Protocol for human islet cell transplantation, which was published in the New England Journal of Medicine in the year 2000. ... Read More

Key Insights

• 🚚 Islet cells are transplanted into the liver for improved blood sugar control, utilizing glucose receptors for communication.
• 👨‍🔬 Stem cell research shows promise for future diabetes treatments, but challenges in differentiation and safety remain.
• ❓ Immunosuppressive drugs used after islet transplants may have side effects but are generally well-tolerated by patients.
• 👨‍🔬 Clinical trials for islet cell transplants could benefit from broader inclusion criteria, but funding and research coordination are essential.

Questions & Answers

Q: How do islet cells communicate with the body and regulate blood sugar?

Islet cells have glucose receptors and produce insulin in response to blood sugar levels, maintaining balance without nerve innervation.

Q: What are the risks and benefits of immunosuppressive drugs for islet transplant recipients?

Immunosuppressive drugs are generally well-tolerated, but may have side effects like tremors and swelling, along with increased risk of cancers and infections.

Q: Why do islet transplants focus on brittle diabetes patients, and are there plans to expand inclusion criteria?

Initial trials targeted brittle diabetes patients for maximum impact, but broader inclusion criteria may be considered with further research and randomized controlled trials.

Q: How do stem cells differentiate into islet cells for transplantation, and what challenges exist in this process?

Stem cells can be manipulated to become islet-like cells, but challenges remain in ensuring their stability, safety, and long-term effectiveness.

Summary & Key Takeaways

• Dr. Shapiro introduces advancements in diabetes research, focusing on islet cell transplantation.

• Islet cells, critical for insulin production, are transplanted into the liver to regulate blood sugar effectively.

• Stem cell research shows promise for future treatments, with ongoing trials and considerations for broader patient inclusion.